|
WO9925319A1
|
|
Production of multivesicular liposomes
|
|
US5891467A
|
|
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
|
US5931809A
|
|
Epidural administration of therapeutic compounds with sustained rate of release
|
|
US5723147A
|
|
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
|
US5807572A
|
|
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
|
US5576017A
|
|
Heterovesicular liposomes
|
|
AU1053595A
|
|
Vesicles with controlled release of actives
|
|
US5422120A
|
|
Heterovesicular liposomes
|
|
WO9426250A1
|
|
Method for treating neurological disorders
|
|
US5455044A
|
|
Method for treating neurological disorders
|
|
CA2162854A1
|
|
Method for treating neurological disorders
|
|
NZ237464A
|
|
Liposomes with at least two separate chambers encapsulating two separate biologically active substances
|
|
NZ247547A
|
|
Process for preparing heterovesicular lipid vesicles or liposomes; vesicles containing a chloride and an active agent
|
